Fresenius Medical Care Holdings Inc /Ny/ - Aug 26, 2021 Form 3 Insider Report for Humacyte, Inc. (HUMA)

Role
10%+ Owner
Signature
FRESENIUS MEDICAL CARE HOLDINGS, INC. /s/ Mark Fawcett By: Mark Fawcett Senior Vice President and Treasurer
Stock symbol
HUMA
Transactions as of
Aug 26, 2021
Transactions value $
$0
Form type
3
Date filed
9/2/2021, 06:05 AM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HUMA Common Stock, par value $0.0001 per share 18.3M Aug 26, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Excludes the Reporting Person's pro rata share of up to 15,000,000 additional shares of the Issuer's Common Stock which may become issuable to the former shareholders of Humacyte, Inc. pursuant to the terms of the Business Combination Agreement dated as of February 17, 2021 by and among the Issuer, Hunter Merger Sub, Inc. and Humacyte, Inc., as to which the Reporting Person disclaims any present beneficial ownership interest.
F2 Fresenius Medical Care Holdings, Inc. is an indirect, wholly-owned subsidiary of Fresenius Medical Care AG & Co. KGaA ("FMC AG & Co. KGaA"). FMC AG & Co. KGaA's address is Else-Kroner Strasse 1, 61352 Bad Homburg, Germany.